Recent Updates
Recently added Catalysts
ORIC Positive Sentiment

ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Tuesday, January 2, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ORIC Pharmaceuticals, a clinical-stage oncology company, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024. CEO Jacob M. Chacko will provide a company overview, which will also be accessible via a webcast. This event showcases ORIC's ongoing efforts to engage with investors and highlight its focus on addressing therapeutic resistance in cancer treatment.
Price reaction · baseline $9.2 (2023-12-29 close) · hit after-hours · clean, no other ORIC news in the window
day 0 close
-0.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Company is actively participating in a major healthcare conference.
  • Presentation opportunity highlights ORIC's commitment to communicating with investors.
  • Focus on developing innovative treatments in oncology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+58%
120-day peak, hindsight
Typical move
10.1%
average across 6 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
ORIC-944
Phase 1 · Metastatic Prostate Cancer

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 11:15 a.m. PT.
A live webcast of the company presentation will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcast will be available for 90 days following the events.
About ORIC Pharmaceuticals, Inc.

Frequently Asked Questions

When will ORIC Pharmaceuticals present at the J.P. Morgan Conference?

ORIC Pharmaceuticals will present on January 9, 2024, at 11:15 a.m. PT.

Who is presenting at the J.P. Morgan Healthcare Conference?

CEO Jacob M. Chacko, M.D. will present an overview of the company.

How can I watch the ORIC Pharmaceuticals presentation?

The presentation will be available via a live webcast on their website.

Will there be a replay of the presentation?

Yes, replays of the presentation will be available for 90 days.

Who can I contact for more information about ORIC Pharmaceuticals?

You can contact Dominic Piscitelli, Chief Financial Officer, at his email.

ShareAdd on Google
Tags: ORIC Viatris Investor Conferences Healthcare ORIC Pharmaceuticals J.P. Morgan healthcare conference oncology Jacob Chacko
Last updated: Jan 2, 2024

Biotech snapshot

Cash runway
$388M liquidity · $11M/mo burn
~36 mo
Minimal dilution risk
Lead asset
ORIC-944Phase 1
Metastatic Prostate Cancer →

Catalyst track record

+58%
best trade around ORIC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for ORIC.

See every catalyst's timing & PoA →